Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BBLGW
- Price
- 20.20
- Stock movement up
- +- (%)
- Company name
- Bone Biologics Corp Warrants
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- -
- Ent value
- -3.29M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -67.07%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 22.04%
- 1 year return
- 29.49%
- 3 year return
- 17.98%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-18
DIVIDENDS
BBLGW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -2.36 |
| FCF per share (TTM) | -2.73 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -3.82M |
| Net income (TTM) | -4.14M |
| EPS (TTM) | -2.36 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.57M |
| Net receivables | 0.00 |
| Total current assets | 4.07M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 4.07M |
| Accounts payable | 190.06K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 273.40K |
| Total liabilities | 273.40K |
| Shareholder's equity | 3.79M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.79M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -4.79M |
| Dividends paid (TTM) | 3.21M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -109.18% |
| Return on Assets | -101.84% |
| Return on Invested Capital | -109.18% |
| Cash Return on Invested Capital | -126.29% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 20.20 |
| Daily high | 20.20 |
| Daily low | 20.20 |
| Daily Volume | 0K |
| All-time high | 95.00 |
| 1y analyst estimate | - |
| Beta | 0.74 |
| EPS (TTM) | -2.36 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BBLGW | S&P500 | |
| Current price drop from All-time high | -78.74% | -4.55% |
| Highest price drop | -98.80% | -56.47% |
| Date of highest drop | 9 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -67.20% | -11.07% |
| Avg time to new high | 23 days | 12 days |
| Max time to new high | 636 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Employees
2
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner